WebDisclosure WebDisclosure
Basculer en Français
10965 Companies
240124 Keywords
168894 Articles
129222 Press releases
Headlines Articles Press releases JAGGERBYTE Remove
  1. Home
  2. Companies
  3. JAGGERBYTE
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/15/2024 at 20:05, 2 years 5 months ago

    Game Pill Announces New Indie Title "Hangry" - An Action RPG with a Culinary Twist

    Unreal Engine Indie Games Action RPG Game Development Steam
  • BRIEF

    published on 03/15/2024 at 20:05, 2 years 5 months ago

    Game Pill annonce un nouveau titre indépendant "Hangry" - un RPG d'action avec une touche culinaire

    Jeux Indie Action-RPG Développement De Jeu Moteur Irréel Vapeur
  • PRESS RELEASE

    published on 03/15/2024 at 20:00, 2 years 5 months ago

    Game Pill’s New Snack ‘N’ Slash Action RPG Hangry Serves Up Delicious Dishes and Carnivorous Combat

    Game Pill introduces Hangry, a new indie snack 'n' slash action RPG where players embody the character Hangry on an intergalactic quest. Catch a sneak peek at The MIX during GDC!
    Action RPG Game Pill Hangry Indie Game GDC
    Logo of JAGGERBYTE
Accesswire
  • Published on 09/11/2026 at 17:00, 3 hours 57 minutes ago

    Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors

  • Published on 09/11/2026 at 17:00, 3 hours 57 minutes ago

    Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan

  • Published on 09/11/2026 at 15:25, 5 hours 32 minutes ago

    Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity

  • Published on 09/11/2026 at 15:00, 5 hours 57 minutes ago

    Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update

  • Published on 09/11/2026 at 14:30, 6 hours 27 minutes ago

    AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 19:44, 1 hour 12 minutes ago

    DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031

  • Published on 09/11/2026 at 18:15, 2 hours 42 minutes ago

    CGTN: How BRICS creates new opportunities for Global South development

  • Published on 09/11/2026 at 18:07, 2 hours 50 minutes ago

    Holding(s) in Company

  • Published on 09/11/2026 at 18:06, 2 hours 50 minutes ago

    Cairn Homes Plc: Holding(s) in Company

  • Published on 09/11/2026 at 18:00, 2 hours 57 minutes ago

    ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 13 hours 57 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 13 hours 57 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 13 hours 57 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 13 hours 57 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 1 day 1 hour ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy